Clinical Trials on Rheumatoid Arthritis in Ireland

Total 327 results

University of Limerick

Completed

A Physiotherapist Led Intervention to Promote Physical Activity in Rheumatoid Arthritis - a Pilot Study (PIPPRA)

Rheumatoid Arthritis

Ireland
University of Limerick

Completed

A MEDiterranean Diet in Rheumatoid Arthritis

Rheumatoid Arthritis

Ireland
University Hospital of Limerick
University of Limerick

Completed

Sleep and Exercise in Rheumatoid Arthritis

Rheumatoid Arthritis | Inflammatory Arthritis

Ireland
AbbVie (prior sponsor, Abbott)
JSS Medical Research Inc.; Clinical Trial End-Point (CTEP) Ltd

Completed

A Study on the Prevalence of the Modified Citrullinated Vimentin Anti-body (Anti-MCV) in an Irish Rheumatoid Arthritis (RA) Population and to Assess the Impact of Anti-MCV and the Anti-cyclic-citrullinated Peptide Antibody (Anti-CCP) Status on the Management of Irish Patients With Early RA

Rheumatoid Arthritis

Ireland
University College Dublin

Unknown

Study Examining the Effect of Exercise in People With Rheumatoid Arthritis Taking Anti-TNFalpha Medication

Arthritis, Rheumatoid

Ireland
University College Cork

Unknown

A Trial to Determine the Effects of Exercise in Inflammatory Bowel Disease and Rheumatoid Arthritis (ExMET-IBD)

Rheumatoid Arthritis | Inflammatory Bowel Disease

Ireland
Hoffmann-La Roche

Completed

A Study in Patients With Moderate to Severe Active Rheumatoid Arthritis Comparing Different Infusion Durations of RoActemra/Actemra (Tocilizumab) Treatment

Rheumatoid Arthritis

Denmark, Iceland
Astellas Pharma Inc

Completed

Safety, Tolerability and Efficacy Study of the New Medication ASK8007 to Treat Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

United Kingdom, Belgium, Spain, Netherlands, Ireland, Hungary
Pfizer

Completed

Study Comparing The Effect On Disease Activity When Reducing Or Discontinuing Etanercept In Subjects With RA (DOSERA)

Rheumatoid Arthritis

Sweden, Hungary, Denmark, Finland, Iceland, Norway
Bristol-Myers Squibb

Completed

Long Term Experience With Abatacept in Routine Clinical Practice (ACTION)

Rheumatoid Arthritis

France, Italy, Austria, Ireland, Belgium, Spain, Czech Republic, Netherlands, Canada, Denmark, Germany, Greece, Switzerland
National University of Ireland, Galway, Ireland

Unknown

MySlainte: Testing the Effect of Involving Partners in a CVD Prevention Community Lifestyle Program

Chronic Kidney Diseases | Rheumatoid Arthritis | Cardiovascular Risk Factor | Partner, Domestic

Ireland
Western Health and Social Care Trust
University of Ulster

Withdrawn

Dataglove to Measure Joint Stiffness in Patients With Arthritis

Arthritis, Rheumatoid

United Kingdom
Janssen Research & Development, LLC

Completed

A Study of JNJ-67484703 in Participants With Active Rheumatoid Arthritis

Rheumatoid Arthritis

Spain, United States, Hungary, Georgia, Moldova, Republic of, Ukraine
Karolinska Institutet

Active, not recruiting

Active Conventional Therapy Compared to Three Different Biologic Treatments in Early Rheumatoid Arthritis With Subsequent Dose Reduction

Rheumatoid Arthritis

Sweden, Denmark, Finland, Norway, Iceland, Netherlands
UCB Pharma

Completed

Long Term Effects of an Early Response to Certolizumab Pegol (CZP, Cimzia®) in Rheumatoid Arthritis (RA) Patients (RA-PROACTIVE)

Arthritis,Rheumatoid

Ireland, United Kingdom
Pfizer

Completed

Study Evaluating Etanercept Plus Methotrexate in Early Rheumatoid Arthritis

Active Rheumatoid Arthritis | Arthritis, Rheumatoid | Rheumatoid Arthritis

Italy, Spain, Switzerland, France, Germany, Poland, Netherlands, United Kingdom, Monaco, Romania, Ireland, Qatar, Russian Federation
Johnson & Johnson Pharmaceutical Research & Development...

Terminated

An Efficacy and Safety Study of JNJ-38518168 in Adult Participants With Rheumatoid Arthritis

Rheumatoid Arthritis

Poland, United Kingdom, Taiwan, Spain, Korea, Republic of, Belgium, Russian Federation, Czech Republic, Netherlands, Ireland
Canadian Research & Education in Arthritis
Abbott

Completed

Assess Structural Damage in Rheumatoid Arthritis Using Biomarkers and Radiography

Rheumatoid Arthritis

United States, Canada, Italy, Israel, Denmark, France, Germany, Ireland, Netherlands, Norway
Regeneron Pharmaceuticals
Sanofi

Completed

Single-dose Study to Describe the Pharmacodynamics (PD) and Safety of Sarilumab (REGN88/SAR153191) and Tocilizumab in Adults With Rheumatoid Arthritis (RA)

Rheumatoid Arthritis

United States
AbbVie (prior sponsor, Abbott)

Completed

Efficacy and Safety of Adalimumab and Methotrexate (MTX) Versus MTX Monotherapy in Subjects With Early Rheumatoid Arthritis (PREMIER)

Early Rheumatoid Arthritis

United States, Australia, Austria, Belgium, Canada, Czech Republic, Denmark, Finland, France, Germany, Ireland, Italy, Netherlands, Norway, Slovakia, Spain, Sweden, Switzerland, United Kingdom
Corin

Completed

Post-PMA Approval Study: 10 Year Follow-Up IDE Subjects (PAS:IDE)

Osteoarthritis | Rheumatoid Arthritis | Avascular Necrosis

United States
Hoffmann-La Roche

Completed

A Study of Subcutaneous RoActemra/Actemra (Tocilizumab) as Monotherapy or in Combination With Methotrexate or Other Non-Biologic DMARDs in Patients With Active Rheumatoid Arthritis

Rheumatoid Arthritis

Spain, Portugal, Ireland
AbbVie (prior sponsor, Abbott)

Completed

Study to Determine the Effects of Different Doses of Methotrexate (MTX) When Taken With Adalimumab in Subjects With Early Rheumatoid Arthritis (RA) (CONCERTO)

Early Rheumatoid Arthritis

United States, Argentina, Austria, Belgium, Canada, Czech Republic, Germany, Poland, Puerto Rico, Spain
Catalyst OrthoScience

Recruiting

Catalyst CSR Shoulder System for Semi or Total Shoulder Arthroplasty

Osteoarthritis Shoulder | Avascular Necrosis of the Head of Humerus | Rheumatoid Arthritis Shoulder

United States
Bristol-Myers Squibb

Completed

Methotrexate-Inadequate Response Study

Rheumatoid Arthritis (RA)

Italy, Korea, Republic of, Mexico, Taiwan, United States, Chile, France, Poland, United Kingdom, Argentina, Belgium, Ireland, Germany, Netherlands, Canada, India, Russian Federation, Turkey, Australia, South Africa, Brazil, Hungary, Per... and more
AbbVie

Completed

A Phase 3 Study to Compare Upadacitinib to Abatacept in Subjects With Rheumatoid Arthritis on Stable Dose of Conventional Synthetic Disease- Modifying Antirheumatic Drugs (csDMARDs) Who Have an Inadequate Response or Intolerance to Biologic DMARDs

Rheumatoid Arthritis (RA)

United States, Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, Czechia, Germany, Greece, Hungary, Ireland, Israel, Italy, Korea, Republic of, Latvia, Mexico, Netherlands, New Zealand, Poland, Portugal, Puerto Rico, Romania, Russian... and more
Pfizer

Completed

Safety and Tolerability Study Of PF-06835375 In Subjects With Seropositive Systemic Lupus Erythematosus Or Rheumatoid Arthritis

Rheumatoid Arthritis | Systemic Lupus Erythematosus

United States
AbbVie

Completed

A Study to Investigate the Safety and Efficacy of ABBV-105 Alone or in Combination With Upadacitinib (ABBV-599 Combination) in Participants With Active Rheumatoid Arthritis

Rheumatoid Arthritis (RA)

United States, Belgium, Canada, Czechia, Hungary, Poland, Puerto Rico, Spain, United Kingdom
Scipher Medicine

Completed

A Clinical Utility Study of PrismRA for Rheumatoid Arthritis (DRIVE)

Rheumatoid Arthritis

United States
UCB Pharma

Completed

Open Label Long-Term Safety Study of Certolizumab Pegol (CZP) for Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

United States, United Kingdom, Belgium, Germany, Austria, Ireland, Czechia
Mallinckrodt

Completed

Safety and Efficacy of Extracorporeal Photoimmune Therapy With UVADEX for the Treatment of Rheumatoid Arthritis (RA-1)

Rheumatoid Arthritis

France, Italy, United States, Austria, Australia, Belgium, Canada, Germany, Mexico, Slovakia, South Africa
Bristol-Myers Squibb

Completed

Phase I/II Multiple-Dose LEA29Y vs CTLAG4Ig vs Placebo in Rheumatoid Arthritis

Rheumatoid Arthritis

United States, Netherlands, Belgium, Canada, Germany, France, Ireland, Switzerland, United Kingdom
Novartis Pharmaceuticals

Completed

A Biomarker Study of Secukinumab in Rheumatoid Arthritis (RA) Patients

Rheumatoid Arthritis

Germany, United States, Belgium, Russian Federation, United Kingdom
AbbVie

Active, not recruiting

A Study of Oral Upadacitinib Tablets to Assess Treatment Patterns, Achievement of Treatment Targets and Maintenance of Response in Adult Participants With Moderate to Severe Rheumatoid Arthritis (UPHOLD)

Rheumatoid Arthritis (RA)

Argentina, Australia, Austria, Belgium, France, Germany, Greece, Ireland, Israel, Italy, Kuwait, Mexico, Russian Federation, Saudi Arabia, Spain, Switzerland, Taiwan, United Arab Emirates, Uruguay
Bristol-Myers Squibb

Completed

Proof-of-Concept Study With BMS-817399 to Treat Moderate to Severe Rheumatoid Arthritis (RA)

Rheumatoid Arthritis

Korea, Republic of, United States, Mexico, Spain, Russian Federation, South Africa, Argentina
AbbVie

Terminated

Study to Evaluate Adverse Events and Change in Disease Activity in Participants Between 18 to 75 Years of Age Treated With Subcutaneous (SC) Injections of ABBV-154 for Moderately to Severely Active Rheumatoid Arthritis (RA)

Rheumatoid Arthritis (RA)

United States, Australia, Canada, Czechia, Germany, Greece, Hungary, Israel, Italy, Japan, Korea, Republic of, Netherlands, New Zealand, Poland, Puerto Rico, Russian Federation, Slovakia, Spain, Taiwan, Turkey, Ukraine
Bristol-Myers Squibb

Completed

Abatacept With Methotrexate- Phase IIB

Rheumatoid Arthritis

Belgium, United States, Canada, Germany, United Kingdom, Australia, France, Ireland, Netherlands, Argentina, South Africa
Bristol-Myers Squibb

Completed

Study of Abatacept (BMS-188667) in Subjects With Active Rheumatoid Arthritis on Background Non-biologic DMARDS (Disease Modifying Antirheumatic Drugs) Who Have an Inadequate Response to Anti-TNF Therapy

Rheumatoid Arthritis

Belgium, Spain, United States, Germany, Italy, Mexico, United Kingdom, France, Czech Republic, Ireland
AbbVie (prior sponsor, Abbott)

Completed

A Study to Determine the Effect of Methotrexate (MTX) Dose on Clinical Outcome and Ultrasonographic Signs in Subjects With Moderately to Severely Active Rheumatoid Arthritis (RA) Treated With Adalimumab (MUSICA) (MUSICA)

Rheumatoid Arthritis

United States, Puerto Rico
Genmab

Terminated

Trial With HuMax-CD4 in Participants With Rheumatoid Arthritis (RA) Failing Treatment With Methotrexate (MTX) and a TNF-alpha Blocker

Rheumatoid Arthritis

United States, Canada
Amgen

Terminated

Safety and Efficacy of AMG 827 in Subjects With RA

Rheumatoid Arthritis

United States, Poland, Canada, Bulgaria, Latvia, Czechia, Mexico, United Kingdom
Hoffmann-La Roche
Biogen

Completed

A Study of the Efficacy and Safety of Re-treatments With Rituximab in Patients With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Anti-tnfa Therapies

Rheumatoid Arthritis

Belgium, Germany, Norway, United Kingdom, United States, Ireland, France, Canada, Israel, Netherlands, Italy
Zimmer Biomet

Active, not recruiting

A Multicentre Observational Study to Evaluate Clinical Outcomes of the G7 Acetabular System

Rheumatoid Arthritis | Noninflammatory Degenerative Joint Disease

Netherlands, France, Spain, United States, Germany, Ireland
Hoffmann-La Roche

Completed

A Study of P38 Inhibitor (4) in Patients With Active Rheumatoid Arthritis (RA) on Stable Methotrexate Therapy

Rheumatoid Arthritis

Germany, Poland, United States, Australia, Brazil, Canada, Estonia, Greece, Ireland, Mexico, New Zealand, South Africa, Spain, United Kingdom
AbbVie

Completed

A Study to Compare Upadacitinib (ABT-494) to Placebo in Adults With Rheumatoid Arthritis on Stable Dose of Conventional Synthetic Disease-Modifying Antirheumatic Drugs (csDMARDs) With an Inadequate Response or Intolerance to Biologic DMARDs (SELECT-BEYOND)

Rheumatoid Arthritis

United States, Australia, Austria, Belgium, Canada, Czechia, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Israel, Korea, Republic of, Latvia, New Zealand, Poland, Portugal, Puerto Rico, Russian Federation, Slovakia, ... and more
Abbott

Completed

Long Term Open Label Continuation Study

Rheumatoid Arthritis

United States, Canada
Eli Lilly and Company
Incyte Corporation

Recruiting

A Study of Baricitinib in Participants With Rheumatoid Arthritis (RA-BRANCH)

Rheumatoid Arthritis

United States
UCB Pharma SA

Completed

A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adults With Early Active Rheumatoid Arthritis (C-early)

Rheumatoid Arthritis

Germany, United States, Argentina, Australia, Austria, Belgium, Canada, Colombia, Czechia, France, Hungary, Ireland, Italy, Mexico, Monaco, Netherlands, Poland, Romania, Spain, Sweden, Switzerland, United Kingdom
UCB Pharma

Completed

A Comparison of Two Assessment Tools in Predicting Treatment Success of Cimzia in Rheumatoid Arthritis Subjects (PREDICT)

Rheumatoid Arthritis

United States
UCB Pharma

Completed

A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adults With Early Active Rheumatoid Arthritis (C-early)

Rheumatoid Arthritis

Germany, United States, Argentina, Australia, Austria, Belgium, Canada, Colombia, Czechia, France, Hungary, Ireland, Italy, Mexico, Monaco, Netherlands, Poland, Romania, Spain, Sweden, Switzerland, United Kingdom

Clinical Trials on Rheumatoid Arthritis in Ireland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Hungary

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations